OCM
Osterweis Capital Management Portfolio holdings
AUM
$2.09B
1-Year Return
16.35%
This Quarter Return
+11.43%
1 Year Return
+16.35%
3 Year Return
+73.98%
5 Year Return
+137.82%
10 Year Return
+432.96%
AUM
$1.7B
AUM Growth
+$127M
(+8.1%)
Cap. Flow
-$230M
Cap. Flow
% of AUM
-13.48%
Top 10 Holdings %
Top 10 Hldgs %
33.14%
Holding
219
New
16
Increased
24
Reduced
75
Closed
18
Top Buys
| 1 |
Sweetgreen
SG
|
$9.6M |
| 2 |
Bio-Techne
TECH
|
$8.61M |
| 3 |
Duolingo
DUOL
|
$7.76M |
| 4 |
Skechers
SKX
|
$7.18M |
| 5 |
Adobe
ADBE
|
$6.82M |
Top Sells
| 1 |
Kenvue
KVUE
|
$17.8M |
| 2 |
Microsoft
MSFT
|
$9.82M |
| 3 |
Ametek
AME
|
$8.75M |
| 4 |
Novartis
NVS
|
$8.06M |
| 5 |
Insulet
PODD
|
$7.79M |
Sector Composition
| 1 | Technology | 24.41% |
| 2 | Healthcare | 16.08% |
| 3 | Industrials | 11.11% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Consumer Staples | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Verra Mobility
VRRM
$3.99B
| $8.25M | 0.48% |
330,580
+11,035
| +3% | +$276K |
|
|
52
Duolingo
DUOL
$12.5B
| $7.76M | 0.46% |
+35,164
| New | +$7.76M |
|
|
53
Novartis
NVS
$249B
| – | – |
0
| – | -$8.06M |
|
54
DoubleVerify
DV
$2.5B
| $7.49M | 0.44% |
213,085
-13,100
| -6% | -$461K |
|
55
Inspire Medical Systems
INSP
$2.55B
| $7.24M | 0.43% |
33,686
+4,709
| +16% | +$1.01M |
|
|
56
Skechers
SKX
$9.5B
| $7.18M | 0.42% |
+117,240
| New | +$7.18M |
|
57
ACM Research
ACMR
$1.73B
| $7.09M | 0.42% |
243,186
-119,950
| -33% | -$3.5M |
|
58
UFP Technologies
UFPT
$1.61B
| $7.06M | 0.41% |
27,981
+982
| +4% | +$248K |
|
59
Manhattan Associates
MANH
$12.7B
| $6.98M | 0.41% |
27,905
-2,002
| -7% | -$501K |
|
60
Clearwater Analytics
CWAN
$5.9B
| $6.13M | 0.36% |
346,480
-186,630
| -35% | -$3.3M |
|
61
Magnolia Oil & Gas
MGY
$4.56B
| $6.04M | 0.36% |
232,905
-25,075
| -10% | -$651K |
|
62
First Watch Restaurant Group
FWRG
$1.14B
| $6.04M | 0.35% |
+245,315
| New | +$6.04M |
|
63
Boot Barn
BOOT
$5.83B
| $5.88M | 0.35% |
+61,830
| New | +$5.88M |
|
64
Apple
AAPL
$3.56T
| $5.86M | 0.34% |
34,185
-2,350
| -6% | -$403K |
|
65
Amicus Therapeutics
FOLD
$2.47B
| $5.7M | 0.33% |
+484,060
| New | +$5.7M |
|
66
Transmedics
TMDX
$3.55B
| $5.69M | 0.33% |
76,990
+12,425
| +19% | +$919K |
|
67
Celsius Holdings
CELH
$15.7B
| $5.25M | 0.31% |
63,325
-33,530
| -35% | -$2.78M |
|
68
Procept Biorobotics
PRCT
$2.13B
| $5.15M | 0.3% |
+104,155
| New | +$5.15M |
|
69
Progyny
PGNY
$2.03B
| $5.04M | 0.3% |
132,085
-65,145
| -33% | -$2.49M |
|
70
Autodesk
ADSK
$68.1B
| $4.18M | 0.25% |
16,060
-2,000
| -11% | -$521K |
|
71
Procter & Gamble
PG
$373B
| $3.21M | 0.19% |
19,757
-205
| -1% | -$33.3K |
|
72
Berkshire Hathaway Class A
BRK.A
$1.09T
| $3.17M | 0.19% |
5
| – | – |
|
73
Modine Manufacturing
MOD
$7.14B
| $3.17M | 0.19% |
+33,290
| New | +$3.17M |
|
74
Enterprise Products Partners
EPD
$68.9B
| $2.61M | 0.15% |
89,280
-5,650
| -6% | -$165K |
|
75
Viking Therapeutics
VKTX
$2.98B
| $2.04M | 0.12% |
+24,845
| New | +$2.04M |
|